Author:
Shi Dongmei,Li Dongmei,Yin Qingxin,Qiu Ying,Yan Hongxia,Shen Yongnian,Lu Guixia,Liu Weida
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.
2. Gaffen SL, Hernandez-Santos N, Peterson AC. IL-17 signaling in host defense against Candida albicans. Immunol Res. 2011;50:181–7.
3. Vandeputte P, Ferrari S, Coste AT. Antifungal resistance and new strategies to control fungal infections. Int J Microbiol. 2012;2012:713687.
4. National Research Council (US) Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials, National Research Council (US) Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation. Treating Infectious Diseases in a Microbial World: Report of Two Workshops on Novel Antimicrobial Therapeutics. Washington, DC: National Academies Press; 2006.
5. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275–88.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献